The calmodulin-binding tetraleucine motif of KCNE4 is responsible for association with Kv1.3.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 11 4 2019
medline: 20 5 2020
entrez: 11 4 2019
Statut: ppublish

Résumé

The voltage-dependent potassium (Kv) channel Kv1.3 regulates leukocyte proliferation, activation, and apoptosis, and altered expression of this channel is linked to autoimmune diseases. Thus, the fine-tuning of Kv1.3 function is crucial for the immune system response. The Kv1.3 accessory protein, potassium voltage-gated channel subfamily E (KCNE) subunit 4, acts as a dominant negative regulatory subunit to both enhance inactivation and induce intracellular retention of Kv1.3. Mutations in KCNE4 also cause immune system dysfunction. Although the formation of Kv1.3-KCNE4 complexes has profound consequences for leukocyte physiology, the molecular determinants involved in the Kv1.3-KCNE4 association are unknown. We now show that KCNE4 associates with Kv1.3

Identifiants

pubmed: 30969795
doi: 10.1096/fj.201801164RR
doi:

Substances chimiques

KCNE4 protein, human 0
KCNE4 protein, mouse 0
KCNE4 protein, rat 0
Kv1.3 Potassium Channel 0
Potassium Channels, Voltage-Gated 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8263-8279

Auteurs

Laura Solé (L)

Departament de Bioquímica i Biomedicina Molecular, Molecular Physiology Laboratory, Institut de Biomedicina (IBUB), Universitat de Barcelona, Barcelona, Spain.
Department of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA.

Sara R Roig (SR)

Departament de Bioquímica i Biomedicina Molecular, Molecular Physiology Laboratory, Institut de Biomedicina (IBUB), Universitat de Barcelona, Barcelona, Spain.

Daniel Sastre (D)

Departament de Bioquímica i Biomedicina Molecular, Molecular Physiology Laboratory, Institut de Biomedicina (IBUB), Universitat de Barcelona, Barcelona, Spain.

Albert Vallejo-Gracia (A)

Departament de Bioquímica i Biomedicina Molecular, Molecular Physiology Laboratory, Institut de Biomedicina (IBUB), Universitat de Barcelona, Barcelona, Spain.

Antonio Serrano-Albarrás (A)

Departament de Bioquímica i Biomedicina Molecular, Molecular Physiology Laboratory, Institut de Biomedicina (IBUB), Universitat de Barcelona, Barcelona, Spain.

Antonio Ferrer-Montiel (A)

Instituto de Biología Molecular y Celular, Universidad Miguel Hernández, Elche, Alicante, Spain.

Gregorio Fernández-Ballester (G)

Instituto de Biología Molecular y Celular, Universidad Miguel Hernández, Elche, Alicante, Spain.

Michael M Tamkun (MM)

Department of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA.

Antonio Felipe (A)

Departament de Bioquímica i Biomedicina Molecular, Molecular Physiology Laboratory, Institut de Biomedicina (IBUB), Universitat de Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH